Guidelines & Publications
Guidelines for Surveillance, Prevention, and Control
Morbidity and Mortality Weekly Reports (MMWR)
Selected Publications in Peer-Reviewed Literature
Baty SA, Gibney KB, Staples JE, et al. Evaluation for West Nile virus (WNV) RNA in urine of patients within 5 months of WNV infection. J Infect Dis 2012;205:1476.
Diamond MS. Progress on the development of therapeutics against West Nile virus. Antiviral Res 2009;83:214–27.
Gibney KB, Edupuganti S, Panella AJ, et al. Detection of yellow fever immunoglobulin M antibodies at 3-4 years following yellow fever vaccination. Am J Trop Med Hyg 2012;87(6):1112-1115.
Gibney KB, Colborn J, Baty S, et al. Modifiable risk factors for West Nile virus infection during an outbreak – Arizona, 2010. Am J Trop Med Hyg 2012;86(5):895-901.
Gibney KB, Lanciotti RS, Sejvar JJ, et al. West Nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis 2011;203(3):344-47.
Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients. N Engl J Med 2003;348:2196-2203.
Janusz KB, Lehman JA, Panella AJ, Fischer M, Staples JE. Laboratory testing practices for West Nile virus in the United States. Vector Borne Zoonotic Dis 2011:11(5):597-599.
Lindsey NP, Brown JA, Kightlinger L, et al. State health department perceived utility of and satisfaction with ArboNET, the U.S. national arboviral surveillance system. Public Health Rep 2012;127:383-390External.
Lindsey NP, Staples JE, Lehman JA, Fischer M. Medical risk factors for severe West Nile virus disease, United States, 2008-2010. Am J Trop Med Hyg 2012;87(1):179-184.
Lindsey NP, Sejvar JJ, Bode AV, Pape WJ, Campbell GL. Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. Vector Borne Zoonotic Dis 2012;12(3):230-235.
Lindsey NP, Hayes EB, Staples JE, Fischer M. West Nile virus in children. Pediatrics 2009;123:e1084-e1089.
Nett RJ, Kuehnert MJ, Ison MG, Orlowski JP, Fischer M, Staples JE. Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis 2012;14(3):268-277.
Montgomery SP, Brown JA, Kuehnert M, et al. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. Transfusion 2006;46:2038-2046.
Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001;358:261-264.
Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;3441:1807-1814.
O’Leary DR, Marfin AA, Montgomery SP, et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004;4:61-70
Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
Petersen LR, Fischer M. Unpredictable and difficult to control: West Nile virus enters adolescence. N Eng J Med 2012;367(14):1281-4.
Petersen LR, Hayes EB. West Nile virus in the Americas. Med Clin N Am 2008; 92:1307-22.
Sejvar JJ, Lindsey NP, Campbell GL. Primary causes of death in reported cases of fatal West Nile fever, United States, 2002-2006. Vector Borne Zoonotic Dis 2011;11(2):161-164.
Sejvar J, Curns A, Welburg L, et al. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol 2008;2(2):477-499.
Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003;290:511-515.
Suthar MS, Diamond MS, Gale M. West Nile virus infection and immunity. Nature Rev 2013;11:115-128.
Weber I, Lindsey N, Bunko-Patterson A, et al. Completeness of West Nile virus testing among patients with meningitis and encephalitis during an outbreak in Arizona. Epidemiol Infect 2012;140:1632-1636.